Private Equity 8 Hours

Last updated: April 22, 2026, 8:30 PM ET

Private Equity Dealmaking & Sector Focus

Private equity-backed Alcami is moving to bolster its pharmaceutical services footprint by acquiring Tjoapack, a move signaling continued consolidation within the contract development and manufacturing organization space. Separately, investment timelines in nascent technology sectors appear to be shifting, as investors are accepting the extended development cycles inherent in fusion energy projects, evidenced by private capital commitments surging from $10 billion to $15 billion in recent months. This willingness to fund long-duration science contrasts sharply with typical venture pacing, suggesting a higher tolerance for capital deployment in deep technology plays. Meanwhile, executive accountability remains in focus following a CEO taking responsibility for a security scare at a portfolio company, a moment that forces boards to re-evaluate governance protocols in high-growth environments.